Ajanta Pharmaceuticals Share Price

ABOUT Ajanta Pharmaceuticals

• Industry Biotechnology & Drugs
• ISIN INE031B01049
• BSE Code 532331
• NSE Code AJANTPHARM

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.

MANAGEMENT

• Madhusudan Agrawal Executive Vice Chairman of the Board
• Arvind Agrawal Chief Financial Officer
• Gaurang Shah Vice President - Legal, Company Secretary
• Rajesh Agrawal Joint Managing Director, Executive Director
• Yogesh Agrawal Managing Director, Executive Director